The Betty Boop Eyelash Drug vs. the Recession

Let our journalists help you make sense of the noise: Subscribe to the Mother Jones Daily newsletter and get a recap of news that matters.


It wasn’t nearly as jarring as it should have been to see these two headlines ‘above the fold’ in the NYTimes earlier this week: “Banks in Need of Even More Bailout Money” and “Love the Long Eyelashes. Who’s Your Doctor?”

Yup. As America crumbles, we’re performing plastic surgery on the dead and gearing up to pay $120 a month for stupid eyelashes. First it was frozen foreheads. Now it’s Betty Boop eyelashes.

Allergan, the company that turned an obscure muscle paralyzer for eyelid spasms, Botox, into a blockbuster wrinkle smoother, hopes to perform cosmetic alchemy yet again. At the end of the month, the company plans to introduce Latisse, the first federally approved prescription drug for growing longer, lusher lashes.

So what if an already overburdened doctor will have to make time for the hordes of Barbie-obsessed women who’ll need a prescription? So what if the medication (cuz that’s what it is; it’s intended for glaucoma patients) has nasty side effects like changing your eye color, darkening your eye lids,and causing red eye and eye itch? Isn’t that worth a possible 25 percent increase in your lashes?

So what, when this nirvana awaits you:

“People would say to me ‘Are you wearing false eyelashes?’—even my own mother asked,” said Cindy Ross, vice president for sales at Young Pharmaceuticals in Wethersfield, Conn., who participated in the Latisse clinical trial.

Ms. Ross said she liked the effect so much that she had a doctor prescribe the glaucoma drug to use on her lashes until Latisse becomes commercially available. “I wouldn’t stop,” Ms. Ross said. “I found a way to get it.”

So what if it makes you a criminal?

So what, as long as you look marvelous?

Hopefully, there’s a way to cross reference patient numbers (and I think there’ll be more than a few metrosexuals slavering this stuff on their eyes) with bankruptcy filings, or numbers of people demanding help with the mortgages they could never afford.

Am I living in the same America as everyone else? The one where we need to resume the frugality of our grandparents?

DOES IT FEEL LIKE POLITICS IS AT A BREAKING POINT?

Headshot of Editor in Chief of Mother Jones, Clara Jeffery

It sure feels that way to me, and here at Mother Jones, we’ve been thinking a lot about what journalism needs to do differently, and how we can have the biggest impact.

We kept coming back to one word: corruption. Democracy and the rule of law being undermined by those with wealth and power for their own gain. So we're launching an ambitious Mother Jones Corruption Project to do deep, time-intensive reporting on systemic corruption, and asking the MoJo community to help crowdfund it.

We aim to hire, build a team, and give them the time and space needed to understand how we got here and how we might get out. We want to dig into the forces and decisions that have allowed massive conflicts of interest, influence peddling, and win-at-all-costs politics to flourish.

It's unlike anything we've done, and we have seed funding to get started, but we're looking to raise $500,000 from readers by July when we'll be making key budgeting decisions—and the more resources we have by then, the deeper we can dig. If our plan sounds good to you, please help kickstart it with a tax-deductible donation today.

Thanks for reading—whether or not you can pitch in today, or ever, I'm glad you're with us.

Signed by Clara Jeffery

Clara Jeffery, Editor-in-Chief

payment methods

We Recommend

Latest